Keywords
Diagnosis
Biomarkers
Technological advances
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To identify and evaluate new diagnostic approaches for Polycystic Ovary Syndrome (PCOS), focusing on technological advancements, biomarkers, and recent diagnostic criteria that could improve the accuracy and timeliness of diagnosis for this condition. Methods: This integrative review was conducted based on a search in the PubMed Central (PMC) database, using the search terms "diagnosable" OR "diagnosis" AND "polycystic ovary syndrome." The initial search yielded 1,241 articles, of which 63 were selected after applying inclusion and exclusion criteria, resulting in 18 relevant articles for full analysis. Results: Key findings highlight technological advancements and promising biomarkers that may contribute to a more precise diagnosis of PCOS. The innovations discussed in the study suggest that combining new methodologies could lead to faster and more effective identification of the syndrome, benefiting the clinical management of patients. Final considerations: The study emphasizes the importance of ongoing research into PCOS diagnostics, considering current limitations and the need for further evidence.
References
AARESTRUP J, et al. Birthweight, childhood body mass index, height and growth, and risk of polycystic ovary syndrome. Obesity Facts, 2021; 14(3): 283-290.
ALADAG H, et al. Galectin-1 an a potential diagostic biomarker in polycystic ovary syndrome. European Review for Medical and Pharmacological Sciences, 2023; 27(6): 2543-2551.
BADEEB A, et al. Dark cortical rim: an MRI feature of polycystic ovarian syndrome. Abdominal Radiology, 2021; 46: 1148-1156.
BOZDAG G, et al. Anti-Müllerian Hormone as a Diagnostic Tool for Polycystic Ovary Syndrome Under Different Diagnostic Criteria Among Unselected Population. Reproductive BioMedicine Online, 2019; 39(3): 522-529.
CRAIG M, et al. Polycystic Ovarian Syndrome in Adolescents: Early Diagnosis and Intervention. Journal of Pediatric Health Care, 2020; 34(2): 166-170.
CUNDUBEY CR. Serum phoenixin-14 Levels of women with polycystic ovary syndrome increase proportionally with BMI. European Review For Medical And Pharmacological Sciences, 2023; 27(8): 3519-3525.
DESWAL R e DANG AS. Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis. Fertility and sterility, 2020; 113(3): 661-669.
EROGLU S e CAKMAKLIOGULLARI EK. Decreased serum profile of the interleukin-36α in polycystic ovary syndrome. Taiwanese Journal of Obstetrics and Gynecology, 2021; 60(6): 1018-1022.
GAO Q, et al. Exploration of molecular features of PCOS with different androgen levels and immune-related prognostic biomarkers associated with implantation failure. Frontiers in Endocrinology, 2022; 13: 946504.
HASEGAWA Y, et al. Impact of the difference in diagnostic criteria for adolescent polycystic ovary syndrome excluding polycystic ovarian morphology. Journal of Obstetrics and Gynaecology Research, 2024; 50: 1289–1294.
JARRETT BY, et at. Impact of right–left differences in ovarian morphology on the ultrasound diagnosis of polycystic ovary syndrome. Fertility and Sterility, 2019; 112(5): 939-946.
JIANG Y, et al. Serum asprosin level in diferente subtypes of polycytisc ovary syndrome: a cross-sectional study. Revista da Associação Médica Brasileira, 2021; 67 (4): 590-596.
LIU C, et al. The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS. Reproductive Sciences, 2023; 30(2): 633-641.
LONE NM, et al. Genotype-independent association between vitamin D deficiency and polycystic ovarian syndrome in Lahore, Pakistan. Scientific Reports, 2020; 10(1): 2290.
LONG J, et al. Screening for a Simple and Effective Indicator of Insulin Resistance in Chinese Reproductive-Aged Women, with the Insulin Clamp Technique as a Reference. Metabolic syndrome and related disorders, 2019; 17(8): 423-429.
MARTIN RF, et al. Glycoprotein A and B Height-to-Width Ratios as Obesity-Independent Novel Biomarkers of Low-Grade Chronic Inflammation in Women with Polycystic Ovary Syndrome (PCOS). Journal of proteome research, 2019; 18(11): 4038-4045.
PAALANNE M, et al. Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm. European Journal of Endocrinology, 2021; 185(2): 279-288.
PARVEEN S, et al. Association of lipid profile and obesity in patients with polycystic ovary syndrome. Endocrine regulations, 2024; 58 (1): 83-90.
REDDY VS, et al. Circulatory Metastin/Kisspeptin-1 (META KISS-1 Study) in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis with Diagnostic Test Accuracy. Reproductive BioMedicine Online, 2019; 39(4): 685-697.
RUDNICKA E, et al. Hormone in Pathogenesis, Diagnostic and Treatment of PCOS. International Journal of Molecular Sciences, 2021; 22(22): 12507.
TEMUR M, et al. Elevated circulating Selenoprotein P levels in patients with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology, 2022; 42(2): 289-293.
WITCHEL SF, et al. Curtailing PCOS. Pediatric research, 2020; 87(2): 353-361.
ZHANG M, et al. The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study. Reproductive Biology and Endocrinology, 2023; 21(1): 15.